Skip to main content
. 2022 Jan 3;12:773581. doi: 10.3389/fimmu.2021.773581

Table 2.

Cox regression analysis of multivariate for RFS and OS of breast cancer patients.

Variables RFS OS
validation cohort 95%CI p 95%CI p
RIS (high vs. low) 0.079-0.870 0.029 0.083-0.920 0.036
Estrogen receptor status(positive vs. negative) 0.564-1.088 0.145 0.542-1.046 0.009
Progesterone receptor status(positive vs. negative) 0.607-1.162 0.293 0.610-1.168 0.306
Human epidermal growth factor receptor2 status(positive vs. negative) 0.572-3.835 0.419 0.547-3.655 0.474
Laterality(left vs. right) 0.379-2.407 0.922 0.389- 2.470 0.967
Age(≥60 vs. <60) 0.429-5.126 0.533 0.446-5.322 0.495